We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical Announces Key Study Results on Use of Breath Biopsy for Improved Detection of Liver Disease Including NASH and NAFLD

Product News   Sep 23, 2020

 
Owlstone Medical Announces Key Study Results on Use of Breath Biopsy for Improved Detection of Liver Disease Including NASH and NAFLD
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel Assay

Product News

PerkinElmer, Inc. (NYSE: PKI) announced today that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries.

READ MORE

EKF Launches PrimeStore® MTM Pathogenic Sample Collection and Transportation Kit

Product News

EKF Diagnostics announces that it has launched a PrimeStore® MTM sample collection kit which enables convenient and safe collection, transportation and handling of pathogenic samples, including COVID-19 and influenza.

READ MORE

InterVenn Enters into Collaboration With Agilent Technologies

Product News

InterVenn, a San Francisco based biotechnology has announced a collaboration with Agilent Technologies. The signing of the collaboration took place on 7 September 2020, with Mr. Fadzhairi Jabar, InterVenn Malaysia’s General Manager, and Mr. Soh Lam Seng, Agilent’s Malaysia Country Manager, Laboratory Solutions Sales.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE